Nanobiotix S.A. (NANO.PA)
EUR 3.48
(1.93%)
EUR 3.48
(1.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 30.05 Million | 4.77 Million | 10 Thousand | 50 Thousand | 68 Thousand | 3.47 Million |
| Cost of Revenue | -6.15 Million | 1.5 Million | -2.63 Million | -2.27 Million | -2.47 Million | - |
| Gross Profit | 36.2 Million | 3.27 Million | 2.64 Million | 2.32 Million | 2.54 Million | 3.47 Million |
| Operating Expenses | 58.92 Million | 48.99 Million | 48.25 Million | 37.18 Million | 47.49 Million | 33.01 Million |
| Selling, General and Administrative Expenses | 21.66 Million | 17.47 Million | 19.01 Million | 14.21 Million | 18.63 Million | 12.65 Million |
| Research and Development Expenses | 38.39 Million | 31.47 Million | 29.23 Million | 22.92 Million | 28.8 Million | 20.89 Million |
| Other Expenses | -163 Thousand | -43 Thousand | - | -40 Thousand | -52 Thousand | - |
| Cost and Expenses | 56.83 Million | 50.49 Million | 49.81 Million | 38.94 Million | 49.26 Million | 33.01 Million |
| Operating Income | -26.77 Million | -50.49 Million | -49.8 Million | -38.89 Million | -49.19 Million | -30.06 Million |
| Interest Expense | 7.98 Million | 5.83 Million | 671 Thousand | 5 Million | 4.79 Million | 847 Thousand |
| Income Tax Expense | 120 Thousand | -4.08 Million | -2.48 Million | -1.91 Million | -2.43 Million | -3.25 Million |
| Earnings before Tax | -39.58 Million | -61.12 Million | -49.48 Million | -35.5 Million | -53.34 Million | -30.34 Million |
| Net Income | -39.7 Million | -57.04 Million | -47 Million | -33.59 Million | -50.91 Million | -30.34 Million |
| Earnings Per Share Basic | -1.08 | -1.64 | -1.35 | -1.38 | -2.35 | -1.55 |
| Earnings Per Share Diluted | -1.08 | -1.64 | -1.35 | -1.38 | -2.35 | -1.55 |
| Weighted Average Shares Outstanding | 36.75 Million | 34.85 Million | 34.73 Million | 24.38 Million | 21.63 Million | 19.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.92 Million | 34.85 Million | 34.73 Million | 24.38 Million | 21.63 Million | 19.63 Million |
| Gross Margin | 1.20 | 0.69 | 264.70 | 46.50 | 37.37 | 1.00 |
| EBIT Margin | -1.13 | -10.26 | -4824.20 | -742.74 | -697.38 | -8.46 |
| Profit Margin | -1.32 | -11.94 | -4700.30 | -671.80 | -748.75 | -8.72 |
| EBITDA | -34.01 Million | -53.78 Million | -45.6 Million | -31.49 Million | -45.01 Million | -29.44 Million |
| Earnings Before Tax Margin | -0.89 | -10.57 | -4980.20 | -777.84 | -723.41 | -8.64 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 9.28 Million | 32.91 Million | 30.05 Million | 3.29 Million | 3.44 Million | 4.77 Million |
| Cost of Revenue | - | -2.85 Million | -6.15 Million | 740 Thousand | 754 Thousand | 1.5 Million |
| Gross Profit | 9.28 Million | 35.77 Million | 36.2 Million | 2.55 Million | 2.69 Million | 3.27 Million |
| Operating Expenses | 32.94 Million | 34.32 Million | 58.92 Million | 27.92 Million | 23.49 Million | 48.99 Million |
| Selling, General and Administrative Expenses | 10.83 Million | 11.18 Million | - | 10.69 Million | 7.98 Million | - |
| Research and Development Expenses | 21.98 Million | 20.59 Million | - | 17.22 Million | 15.53 Million | - |
| Other Expenses | 121 Thousand | 2.54 Million | -163 Thousand | -14 Thousand | 25 Thousand | -43 Thousand |
| Cost and Expenses | 32.94 Million | 34.32 Million | 60.44 Million | 28.66 Million | 24.24 Million | 50.49 Million |
| Operating Income | -23.65 Million | -1.4 Million | -30.38 Million | -28.66 Million | -24.24 Million | -50.49 Million |
| Interest Expense | - | - | 7.98 Million | - | 3.11 Million | 5.83 Million |
| Income Tax Expense | 144 Thousand | 117 Thousand | -3.81 Million | -1.6 Million | -3.03 Million | -4.08 Million |
| Earnings before Tax | -21.72 Million | -11.48 Million | -43.51 Million | -29.7 Million | -33.71 Million | -61.12 Million |
| Net Income | -21.87 Million | -11.6 Million | -39.7 Million | -28.09 Million | -30.68 Million | -57.04 Million |
| Earnings Per Share Basic | -0.46 | -0.31 | - | -0.80 | -0.88 | - |
| Earnings Per Share Diluted | -0.46 | -0.30 | - | -0.80 | -0.88 | - |
| Weighted Average Shares Outstanding | 47.12 Million | 37.99 Million | 36.92 Million | 35.03 Million | 34.85 Million | 34.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.12 Million | 38.81 Million | 36.92 Million | 35.03 Million | 34.85 Million | 34.85 Million |
| Gross Margin | 1.00 | 1.09 | 1.20 | 0.78 | 0.78 | 0.69 |
| EBIT Margin | -2.50 | 0.04 | - | -8.48 | -6.82 | - |
| Profit Margin | -2.35 | -0.35 | -1.32 | -8.53 | -8.90 | -11.94 |
| EBITDA | -23.24 Million | 1.41 Million | - | -27.92 Million | -23.49 Million | - |
| Earnings Before Tax Margin | -2.55 | -0.04 | -1.01 | -8.71 | -7.03 | -10.57 |
HDELY
1730
WBBW
OLCLY
EGATIF
BLIL